Mesoblast Company
Mesoblast is a medicine company that develops biologic products for the broad field of regenerative medicine.
Technology:
Stem cell therapy, diagnostics
Industry:
Public, Regenerative Medicine
Headquarters:
Melbourne, Victoria, Australia
Zip:
51-100
Founded Date:
2004-01-01
Employees Number:
51-100
Funding Status:
IPO
Acquisitions Number:
3
Investors Number:
3
Total Funding:
412295275
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-03-02
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership